{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:30:31Z","timestamp":1791405031693,"version":"4.3.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Council of Scientific and Industrial Research and University","award":["BSC-0101"],"award-info":[{"award-number":["BSC-0101"]}]},{"name":"Senior Research Fellowship"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbrc.2018.04.078","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:01:56Z","timestamp":1529366516000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Hyperhomocysteinemia and hyperandrogenemia share PCSK9-LDLR pathway to disrupt lipid homeostasis in PCOS"],"prefix":"10.1016","volume":"503","author":[{"given":"Kalyani","family":"Mondal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratip","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed N.","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.04.078_bib1","first-page":"104","article-title":"Polycystic ovary syndrome: current status and future perspective","volume":"6","author":"Barthelmess","year":"2014","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbrc.2018.04.078_bib2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.fertnstert.2008.12.138","article-title":"Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria","volume":"93","author":"Huang","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.bbrc.2018.04.078_bib3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2459\/JCM.0b013e32830b58d4","article-title":"Cardiovascular risk in women with polycystic ovary syndrome","volume":"9","author":"Giallauria","year":"2008","journal-title":"J.\u00a0Cardiovasc. Med."},{"key":"10.1016\/j.bbrc.2018.04.078_bib4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejogrb.2016.08.026","article-title":"Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome","volume":"207","author":"Orio","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.bbrc.2018.04.078_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejogrb.2006.10.015","article-title":"Plasma homocysteine and polycystic ovary syndrome: the missed link","volume":"131","author":"Badawy","year":"2007","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.bbrc.2018.04.078_bib6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/humrep\/deg190","article-title":"Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine","volume":"18","author":"Schachter","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.bbrc.2018.04.078_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/1559827609334518","article-title":"Dyslipidemia and risk of coronary heart disease: role of lifestyle approaches for its management","volume":"3","author":"Leon","year":"2009","journal-title":"Am. J. Lifestyle Med."},{"key":"10.1016\/j.bbrc.2018.04.078_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/AOG.0b013e31820209bb","article-title":"Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia","volume":"117","author":"Wang","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.bbrc.2018.04.078_bib9","series-title":"Experimental Characterization of a Rat Model of Polycystic Ovary Syndrome for Evaluation of Conventional Drugs Used for Induction of Ovulation","author":"Chakraborty","year":"2011"},{"key":"10.1016\/j.bbrc.2018.04.078_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0003-2697(02)00224-5","article-title":"The determination of homocysteine-thiolactone in biological samples","volume":"308","author":"Jakubowski","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrc.2018.04.078_bib11","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.jacc.2011.11.064","article-title":"Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin\/kexin type 9","volume":"59","author":"Melone","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2018.04.078_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1530\/REP-16-0035","article-title":"Molecular cues to the anti-implantation effect of nano-puerarin in rats","volume":"151","author":"Saraswat","year":"2016","journal-title":"Reproduction"},{"key":"10.1016\/j.bbrc.2018.04.078_bib13","doi-asserted-by":"crossref","first-page":"28856","DOI":"10.1074\/jbc.M109.037085","article-title":"Dissection of the endogenous cellular pathways of PCSK9-induced low density lipoprotein receptor degradation: evidence for an intracellular route","volume":"284","author":"Poirier","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.04.078_bib14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.fertnstert.2016.12.017","article-title":"Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life","volume":"107","author":"Pinola","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.bbrc.2018.04.078_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0895-7061(01)02286-5","article-title":"Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats","volume":"15","author":"Miller","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbrc.2018.04.078_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2337\/db07-0617","article-title":"Homocysteine upregulates resistin production from adipocytes in\u00a0vivo and in\u00a0vitro","volume":"57","author":"Li","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2018.04.078_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease","volume":"50","author":"Burghen","year":"1980","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2018.04.078_bib18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/dmrr.872","article-title":"Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?","volume":"24","author":"Corbould","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.bbrc.2018.04.078_bib19","doi-asserted-by":"crossref","first-page":"28792","DOI":"10.1074\/jbc.M500501200","article-title":"Insulin regulates the membrane arrival, fusion, and C-terminal unmasking of glucose transporter-4 via distinct phosphoinositides","volume":"280","author":"Ishiki","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.04.078_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.tibs.2006.02.007","article-title":"Bridging the GAP between insulin signalling and GLUT4 translocation","volume":"31","author":"Watson","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2018.04.078_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2018.04.078_bib22","first-page":"4146","article-title":"Clinical study of serum homocysteine and non-alcoholic fatty Liver disease in euglycemic patients","volume":"22","author":"Hu","year":"2016","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.bbrc.2018.04.078_bib23","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1096\/fj.15-280313","article-title":"WNT5a is required for normal ovarian follicle development and antagonizes gonadotropin responsiveness in granulosa cells by suppressing canonical WNT signalling","volume":"30","author":"Abedini","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.bbrc.2018.04.078_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tem.2009.08.005","article-title":"WNT signalling in ovarian follicle biology and tumorigenesis","volume":"21","author":"Boyer","year":"2010","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2018.04.078_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tibs.2009.10.002","article-title":"GSK3: a multifaceted kinase in Wnt signalling","volume":"35","author":"Wu","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2018.04.078_bib26","doi-asserted-by":"crossref","first-page":"10866","DOI":"10.1073\/pnas.1834480100","article-title":"Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1\/beta-catenin synergy","volume":"100","author":"Jordan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"54","key":"10.1016\/j.bbrc.2018.04.078_bib27","article-title":"Relationship between plasma homocysteine level and lipid profiles in a community-based Chinese population","volume":"16","author":"Momin","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bbrc.2018.04.078_bib28","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1194\/jlr.R200017-JLR200","article-title":"Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet","volume":"44","author":"Deeb","year":"2003","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.bbrc.2018.04.078_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2016.05.013","article-title":"Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis","volume":"84","author":"Di Pietro","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.04.078_bib30","first-page":"9473158","article-title":"Lipid profile in adolescent girls with type 1 diabetes mellitus and hyperandrogenemia","volume":"2016","author":"Zachurzok","year":"2016","journal-title":"Internet J. Endocrinol."},{"key":"10.1016\/j.bbrc.2018.04.078_bib31","article-title":"Insulin and testosterone are associated with elevated intestinal secretion of lipids and lipoproteins in a rodent model of the metabolic and polycystic ovary syndrome","volume":"05","author":"Vine","year":"2014","journal-title":"J.\u00a0Diabetes Metabol."},{"key":"10.1016\/j.bbrc.2018.04.078_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2006.07.028","article-title":"Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice","volume":"46","author":"Hamelet","year":"2007","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2018.04.078_bib33","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI11596","article-title":"Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways","volume":"107","author":"Werstuck","year":"2001","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2018.04.078_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/HJR.0b013e32831e1185","article-title":"Homocysteine increases the risk associated with hyperlipidaemia","volume":"16","author":"Daly","year":"2009","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"10.1016\/j.bbrc.2018.04.078_bib35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MOL.0000000000000114","article-title":"PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells","volume":"25","author":"Lagace","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbrc.2018.04.078_bib36","first-page":"2414","article-title":"5alpha-reductase activity in women with polycystic ovary syndrome","volume":"84","author":"Jakimiuk","year":"1999","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2018.04.078_bib37","first-page":"67","article-title":"Evaluation of 5-alpha reductase activity on cultured fibroblast in patients with hyperandrogenemia","volume":"47","author":"Boda","year":"2009","journal-title":"Rom. J. Intern. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18308477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18308477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T09:34:09Z","timestamp":1576834449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18308477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0006291X18308477"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.078","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperhomocysteinemia and hyperandrogenemia share PCSK9-LDLR pathway to disrupt lipid homeostasis in PCOS","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}